Industry
DxGen and Precision Diabetes Partner to Launch New Diabetes POC Testing Analyzer in US
DxGen Corp. (Seoul, Korea) and Precision Diabetes, Inc. (Raleigh, NC, USA) have entered in an exclusive agreement in the U.S. to launch Epithod AutoDx, a fully-automatic point-of-care (POC) analyzer that measures a comprehensive profile of diabetes tests. More...24 Aug 2022
AACC 2022 Review: International Meetings Rebound After Suffering Long COVID Hiatus
After showing first signs of life with EuroMedLab in Munich (April 10-14) and WorldLab in Seoul (June 26-30), international meetings returned in full force with AACC 2022 held in Chicago on July 24-28. Here’s LabMedica's roundup of latest advances unveiled at the event. More...18 Aug 2022
BD and Accelerate Diagnostics Collaborate to Offer Rapid Antimicrobial Identification and Susceptibility Diagnostics
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) and Accelerate Diagnostics, Inc. (Tucson, AZ, USA) have entered into a worldwide commercial collaboration agreement where BD will offer Accelerate's rapid testing solution for antibiotic resistance and susceptibility offering results in hours, versus one to two days with some traditional laboratory methods. More...16 Aug 2022
Bio-Rad Acquires Curiosity Diagnostics from Scope Fluidics
Bio-Rad Laboratories (Hercules, CA, USA) has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (Warsaw, Poland) for a total consideration of up to USD 170 million, consisting of approximately USD 100 million in cash, and up to USD 70 million in future milestone payments. More...05 Aug 2022
Global Sepsis Diagnostics Market Driven by Rising Demand for Assays and Reagents
The global sepsis diagnostics market is projected to grow at a CAGR of close to 8% from an estimated USD 0.75 billion in 2022 to USD 1.63 billion by the end of 2032, driven mainly by a rise in regulatory approvals of essential diagnostic solutions, and demand for high levels of diagnostic precision and accuracy. More...03 Aug 2022
PerkinElmer Divests Other Businesses to Focus on Life Sciences and Diagnostics
PerkinElmer, Inc. (Waltham, MA; USA) has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital (New York, NY, USA) for total consideration of USD 2.45 billion in cash. More...02 Aug 2022
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Repetitive Pipette
VWR® Stepper Pro
New
HPV Test
Allplex HPV28 Detection
In Other News
IFCC Celebrates 70 Years of Advancing Science of Laboratory Medicine and In Vitro Diagnostics
Medlab Asia and Asia Health to Host First-Ever Live, In-Person Event in Thailand
Bioperfectus and ELITechGroup Collaborate for Monkeypox Virus Testing Across Europe
MEDICA and COMPAMED 2022 Planning Enters Next Stage, Exhibitors Can Still Register
Point of Care Testing Market Driven by New Molecular Diagnostic Technologies
Blood Gas and Electrolyte Analyzers Market to Be Dominated by Portable/Hand-Held Automated Devices
Meridian Bioscience Acquired by SD Biosensor and SJL Partners
Fujirebio's Belgian Acquisition Targets Neurodegenerative Diagnostics
Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
BD and Certest Collaborate on Monkeypox Molecular Diagnostic Test
Global POC Diagnostics Devices and Equipment Market to Surpass USD 50 Billion in 2026
QuidelOrtho Formed by Combining Quidel and Ortho
Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business
Global Lateral Flow Assays Market to Surpass USD 11.5 Billion by 2032 Due to Evolving Applications
Global Rapid Test Kits Market Driven by Immunoassay and Chromatography-Based Tests
Meridian Acquires Euprotein to Further Expand Recombinant Protein Capabilities
Globe Scientific Acquired by L Squared Capital Partners
Study Examines Global Rollout of Rapid Molecular Tests for TB Over Last 12 Years
Global Point-of-Care Testing (POCT) Market to Surpass USD 55 Billion by 2030
BioMérieux Acquires Antibiotic Susceptibility Test Firm Specific Diagnostics
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
